1 recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Recruiting 1 |
Follow AAA617: new trials by email Literature Review of AAA617 trials Research Report on AAA617
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer AAA617 - Prostate Cancer | Phase 4 | Recruiting | Novartis Pharmaceuticals | 700 | 2023-08-14 | 2026-06-04 |
Austria (1) · Belgium (1) · Canada (1) · Czechia (1) · France (1) · Germany (1) · Netherlands (1) · Spain (1) · Sweden (1) · United Kingdom (1) · United States (1)
2023 (1)